Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Institut Curie
University of Michigan Rogel Cancer Center
Barbara Ann Karmanos Cancer Institute
Vanderbilt-Ingram Cancer Center
Georgetown University
University Health Network, Toronto
Hoosier Cancer Research Network
Vanderbilt-Ingram Cancer Center